Langlenatide Uses, Dosage, Side Effects and more
Langlenatide is under investigation in clinical trial NCT03713684 (Efficacy and Safety of Langlenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)).
| Trade Name | Langlenatide |
| Generic | Efpeglenatide |
| Efpeglenatide Other Names | Efpeglenatide, Langlenatide |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
